These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24033708)

  • 1. Cognitive enhancement in children and adolescents: is it in their best interests?
    Gaucher N; Payot A; Racine E
    Acta Paediatr; 2013 Dec; 102(12):1118-24. PubMed ID: 24033708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric neuroenhancement: ethical, legal, social, and neurodevelopmental implications.
    Graf WD; Nagel SK; Epstein LG; Miller G; Nass R; Larriviere D
    Neurology; 2013 Mar; 80(13):1251-60. PubMed ID: 23486879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assent as an ethical imperative in the treatment of ADHD.
    Koshy AJ; Sisti DA
    J Med Ethics; 2015 Dec; 41(12):977-81. PubMed ID: 26112613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuroenhancement in healthy subject? A French case study].
    Micoulaud-Franchi JA; Vion-Dury J; Lancon C
    Therapie; 2012; 67(3):213-21. PubMed ID: 22874487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pearls, perils, and pitfalls in the assessment and treatment of attention-deficit/hyperactivity disorder in adolescents.
    Obioha O; Adesman A
    Curr Opin Pediatr; 2014 Feb; 26(1):119-29. PubMed ID: 24370490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Use of Methylphenidate for Cognitive Enhancement in Young Healthy Adults: The Clinical and Ethical Debates.
    Koren G; Korn L
    J Clin Psychopharmacol; 2021 Mar-Apr 01; 41(2):100-102. PubMed ID: 33666399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological cognitive enhancement in pediatrics.
    Colaneri N; Sheldon M; Adesman A
    Curr Opin Pediatr; 2018 Jun; 30(3):430-437. PubMed ID: 29538047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD).
    NIH Consens Statement; 1998 Nov 16-18; 16(2):1-37. PubMed ID: 10868163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication for children with attentional disorders. American Academy of Pediatrics Committee on Children With Disabilities and Committee on Drugs.
    Pediatrics; 1996 Aug; 98(2 Pt 1):301-4. PubMed ID: 8692637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Better evidence for safety and efficacy is needed before neurologists prescribe drugs for neuroenhancement to healthy people.
    Boot BP; Partridge B; Hall W
    Neurocase; 2012 Jun; 18(3):181-4. PubMed ID: 22007842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practitioner characteristics and the treatment of children and adolescents with attention deficit hyperactivity disorder.
    Mitchell PB; Levy F; Hadzi-Pavlovic D; Concannon PE; Hutchins P; Mulcahy DL; Clarke SD; Salmelainen PA; Warner A; Hughes CF
    J Paediatr Child Health; 2012 Jun; 48(6):483-9. PubMed ID: 22111981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.
    Brown RT; Amler RW; Freeman WS; Perrin JM; Stein MT; Feldman HM; Pierce K; Wolraich ML; ;
    Pediatrics; 2005 Jun; 115(6):e749-57. PubMed ID: 15930203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What are the cognitive effects of stimulant medications? Emphasis on adults with attention-deficit/hyperactivity disorder (ADHD).
    Advokat C
    Neurosci Biobehav Rev; 2010 Jul; 34(8):1256-66. PubMed ID: 20381522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attention-deficit/hyperactivity disorder among adolescents: a review of the diagnosis, treatment, and clinical implications.
    Wolraich ML; Wibbelsman CJ; Brown TE; Evans SW; Gotlieb EM; Knight JR; Ross EC; Shubiner HH; Wender EH; Wilens T
    Pediatrics; 2005 Jun; 115(6):1734-46. PubMed ID: 15930238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADHD in children, adolescents, and adults.
    Katragadda S; Schubiner H
    Prim Care; 2007 Jun; 34(2):317-41; abstract viii. PubMed ID: 17666230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
    Chavez B; Sopko MA; Ehret MJ; Paulino RE; Goldberg KR; Angstadt K; Bogart GT
    Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes.
    Faraone SV; Glatt SJ
    J Clin Psychiatry; 2010 Jun; 71(6):754-63. PubMed ID: 20051220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dealing with requests for pharmacological cognitive enhancement from healthy students.
    Chandramouleeswaran S; Edwin NC; Rajaleelan W
    Indian J Med Ethics; 2016; 1(3):196. PubMed ID: 27474703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current strategies in the diagnosis and treatment of childhood attention-deficit/hyperactivity disorder.
    Rader R; McCauley L; Callen EC
    Am Fam Physician; 2009 Apr; 79(8):657-65. PubMed ID: 19405409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.